Oncothyreon (ONTY) leaps on positive data

Oncothyreon Inc

shares climbed 16.8% to $4.00, following the presentation of positive ONT-380 data in HER2-positive breast cancer at the ASCO. Share volume was 18.1 million, or six times its all-day average